The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
| Status: | Recruiting |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 10/14/2018 |
| Start Date: | October 1, 2018 |
| End Date: | September 15, 2020 |
| Contact: | Meg Christ |
| Email: | mchrist@lhs.org |
| Phone: | 503-413-8199 |
This is a pilot study to test whether PYC can improve climacteric symptoms for women who have
experienced either surgically or medically induced menopause as part of their treatment for
breast or gynecologic cancers.
experienced either surgically or medically induced menopause as part of their treatment for
breast or gynecologic cancers.
Inclusion Criteria:
- Patient currently is undergoing treatment for cancer
- Patient has menopausal symptoms induced either by surgical or medical (patient on
tamoxifen or aromatase inhibitor) interventions for cancer
- > 18 years of age
- Willing to travel to a Legacy Health facility if necessary
- Agree to attend study visits outside of standard of care visits, if needed
- Willing to stop other supplements or medications that are aimed at treating menopausal
symptoms at least 7 days before beginning study treatment
- Willing to engage in pre/post testing and survey/phone calls
Exclusion Criteria:
- Patient is currently undergoing chemotherapy treatment
- < 18 years of age
- Unable to comply with protocol
- Unable to provide written informed consent
- Investigator does not believe study participation is in the best interest of the
patient
- Patient had concurrent menopausal symptoms prior to the start of cancer treatment
- Menopausal symptoms are unrelated to surgical or medical treatment of breast or
gynecologic cancers
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials